AI In Pharma Global Market Opportunities And Strategies To 2030: COVID-19 Growth and Change provides the strategists; marketers and senior management with the critical information they need to assess the global AI in pharma market as it emerges from the COVID 19 shut down.
Description: Where is the largest and fastest growing market for AI in pharma? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The AI in pharma market global report answers all these questions and many more. The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market.It traces the market’s historic and forecast market growth by geography.
It places the market within the context of the wider AI in pharma market; and compares it with other markets.
The report covers the following chapters : Executive Summary – The executive summary section of the report gives a brief overview and summary of the report Report Structure – This section gives the structure of the report and the information covered in the various sections. Introduction – The introduction section of the report gives brief introduction about segmentation by technology, segmentation by drug type and segmentation by application. Market Characteristics – The market characteristics section of the report defines and explains artificial intelligence (AI) in pharma market. This chapter also defines and describes goods and related services covered in the report. Trends And Strategies – This chapter describes the major trends shaping the global artificial intelligence (AI) in pharma market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities. Impact of COVID-19 – This section describes the impact of COVID-19 on the artificial intelligence (AI) in pharma market. Global Market Size And Growth – This section contains the global historic (2015-2020) and forecast (2020-2025), and (2025-2030) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods. Regional Analysis – This section contains the historic (2015-2020) and forecast (2020-2025), and (2025-2030) market values and growth and market share comparison by region. Segmentation – This section contains the market values (2015-2030) and analysis for different segments. Global Macro Comparison – The global artificial intelligence (AI) in pharma market comparison with macro-economic factors gives the artificial intelligence (AI) in pharma market size, percentage of GDP, and average artificial intelligence (AI) in pharma market expenditure. Regional Market Size and Growth – This section contains the region’s market size (2020), historic (2015-2020) and forecast (2020-2025), and (2025-2030) market values, and growth and market share comparison of countries within the region.This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
The market overview sections of the report describe the current size of the market, background information, government initiatives, regulations, regulatory bodies, associations, corporate tax structure, investments, and major companies. Competitive Landscape – This section covers details on the competitive landscape of the global artificial intelligence (AI) in pharma market, estimated market shares and company profiles for the leading players. Key Mergers And Acquisitions – This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years. Market Opportunities And Strategies – This section includes market opportunities and strategies based on findings of the research.This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets.
It gives an understanding of where there is significant business to be gained by competitors in the next five years. Conclusions And Recommendations – This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for AI in pharma companies in terms of product offerings, geographic expansion, marketing strategies and target groups. Appendix – This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Scope Markets Covered: 1) By Technology: Context-Aware Processing; Natural Language Processing; Querying Method; Deep Learning 2) By Drug Type: Small Molecule; Large Molecule 3) By Application: Clinical Trial Research; Drug Discovery; Research And Development; Others
Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Brazil; France; Germany; UK; Russia
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; AI in pharma indicators comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Reasons to Purchase • Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies. • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates. • Create regional and country strategies on the basis of local data and analysis. • Identify growth segments for investment. • Outperform competitors using forecast data and the drivers and trends shaping the market. • Understand customers based on the latest market research findings. • Benchmark performance against key competitors. • Utilize the relationships between key data sets for superior strategizing. • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Our reports have been used by over 10K customers, including:
The cleanroom technologies market is projected to reach USD 9.6 billion by 2026 from USD 7.1 billion in 2021, at a CAGR of 6.2% during the forecast period. The growth of this market is majorly driven by the stringent regulatory framework, growth of the biologics sector, rising demand for sterilized pharmaceutical formulations, increasing demand...
275 pages •
By Asia Market Information & Development Company
• Jan 2022
China’s demand for Pharmaceuticals has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption...
The Global Pharmaceutical Contract Manufacturing Organization (CMO) Market was valued at USD 120.29 billion in 2020, and it is expected to reach USD 195.70 billion by 2026, registering a CAGR of 7.85% from 2021 to 2026. COVID-19 pandemic has had a beneficial effect on contract manufacturing services overall. There were multiple opportunities...
Executive Summary The global Active Pharmaceutical Ingredients (API) Market was valued at USD 179.6 Billion in the year 2020. Growth opportunities for the Active Pharmaceutical Ingredient market is attributed to the growth of the geriatric population, rising technical advancements, increasing API manufacturing facilities...
The small molecule drug discovery market was valued at approximately USD 32,150 million in 2020, and it is expected to reach 51,160 million by 2026, registering a CAGR of nearly 8.05% during the forecast period, 2021-2026. Amid the COVID-19 pandemic, the health systems of countries have been heavily investing in research and development...
The dimethyl carbonate market is projected to grow from USD 847 million in 2021 to USD 1,148 million by 2026, at a CAGR of 6.3% from 2021 to 2026. Rising demand for lithium-ion batteries from electronics industry to drive the dimethyl carbonate market. Based on application, the battery electrolyte segment is projected to grow at the highest...
The Medium-chain triglycerides market is estimated at USD 763 million in 2021 and is projected to grow at a CAGR of 6.3% to reach USD 1,034 million by 2026.Increasing incorporation of medium-chain triglycerides as an alternative to regular fats in diet. Its natural and safe nature of ingredients leads to wide range of its applications. With...
The injectable drugs market is expected to register a CAGR of nearly 11.1 % during the forecast period. Currently, big pharma giants are seeking collaborations and approvals to come up with a vaccine in the market space, to prevent the spread of COVID-19 as soon as possible. These vaccines are majorly given in the injectable form,...
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Active Pharmaceutical Ingredients Market Report The active pharmaceutical ingredients market is expected to reach USD 266.80 billion by 2026, growing at a CAGR of 6.22%. The following factors are likely to contribute to the growth of...
The pharmaceutical processing seals market is estimated to be USD 2.1 Billion in 2021 and is projected to reach USD 3.3 Billion by 2026, at a CAGR of 10.0%. Manufacturing equipment is the major application of pharmaceutical processing seals. Capacity expansion and constant innovation in the pharmaceutical industry are expected to drive the...
Gasket And Seal
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.